S&P 500   3,850.05 (-1.92%)
DOW   31,528.31 (-1.36%)
QQQ   315.53 (-2.65%)
AAPL   122.47 (-2.30%)
MSFT   231.06 (-1.49%)
FB   257.60 (-2.54%)
GOOGL   2,026.01 (-2.77%)
AMZN   3,085.71 (-2.34%)
TSLA   696.09 (-6.19%)
NVDA   537.49 (-7.32%)
BABA   243.60 (-2.69%)
CGC   33.79 (-5.08%)
GE   12.85 (-2.06%)
MU   89.81 (-2.93%)
NIO   47.77 (-7.89%)
AMD   83.06 (-4.46%)
T   28.72 (-2.25%)
F   11.90 (-3.02%)
ACB   11.05 (-5.07%)
DIS   193.25 (-2.16%)
BA   219.99 (-4.08%)
NFLX   540.86 (-2.27%)
BAC   36.18 (-0.55%)
S&P 500   3,850.05 (-1.92%)
DOW   31,528.31 (-1.36%)
QQQ   315.53 (-2.65%)
AAPL   122.47 (-2.30%)
MSFT   231.06 (-1.49%)
FB   257.60 (-2.54%)
GOOGL   2,026.01 (-2.77%)
AMZN   3,085.71 (-2.34%)
TSLA   696.09 (-6.19%)
NVDA   537.49 (-7.32%)
BABA   243.60 (-2.69%)
CGC   33.79 (-5.08%)
GE   12.85 (-2.06%)
MU   89.81 (-2.93%)
NIO   47.77 (-7.89%)
AMD   83.06 (-4.46%)
T   28.72 (-2.25%)
F   11.90 (-3.02%)
ACB   11.05 (-5.07%)
DIS   193.25 (-2.16%)
BA   219.99 (-4.08%)
NFLX   540.86 (-2.27%)
BAC   36.18 (-0.55%)
S&P 500   3,850.05 (-1.92%)
DOW   31,528.31 (-1.36%)
QQQ   315.53 (-2.65%)
AAPL   122.47 (-2.30%)
MSFT   231.06 (-1.49%)
FB   257.60 (-2.54%)
GOOGL   2,026.01 (-2.77%)
AMZN   3,085.71 (-2.34%)
TSLA   696.09 (-6.19%)
NVDA   537.49 (-7.32%)
BABA   243.60 (-2.69%)
CGC   33.79 (-5.08%)
GE   12.85 (-2.06%)
MU   89.81 (-2.93%)
NIO   47.77 (-7.89%)
AMD   83.06 (-4.46%)
T   28.72 (-2.25%)
F   11.90 (-3.02%)
ACB   11.05 (-5.07%)
DIS   193.25 (-2.16%)
BA   219.99 (-4.08%)
NFLX   540.86 (-2.27%)
BAC   36.18 (-0.55%)
S&P 500   3,850.05 (-1.92%)
DOW   31,528.31 (-1.36%)
QQQ   315.53 (-2.65%)
AAPL   122.47 (-2.30%)
MSFT   231.06 (-1.49%)
FB   257.60 (-2.54%)
GOOGL   2,026.01 (-2.77%)
AMZN   3,085.71 (-2.34%)
TSLA   696.09 (-6.19%)
NVDA   537.49 (-7.32%)
BABA   243.60 (-2.69%)
CGC   33.79 (-5.08%)
GE   12.85 (-2.06%)
MU   89.81 (-2.93%)
NIO   47.77 (-7.89%)
AMD   83.06 (-4.46%)
T   28.72 (-2.25%)
F   11.90 (-3.02%)
ACB   11.05 (-5.07%)
DIS   193.25 (-2.16%)
BA   219.99 (-4.08%)
NFLX   540.86 (-2.27%)
BAC   36.18 (-0.55%)
Log in
BATS:PBUS

Invesco PureBeta MSCI USA ETF Stock Forecast, Price & News

$40.07
+0.37 (+0.93 %)
(As of 02/24/2021 12:00 AM ET)
Add
Today's Range
$39.20
Now: $40.07▼
$40.11
50-Day Range
$38.17
MA: $39.33▼
$40.39
52-Week Range
$24.94
Now: $40.07▼
$28.08
Volume7,230 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Basic Details

Issuer Invesco
Fund NameInvesco PureBeta MSCI USA ETF
Tax ClassificationRegulated Investment Company
SymbolBATS:PBUS
Inception Date9/19/2017
Fund ManagerPeter Hubbard, Michael Jeanette, Jonathan Nixon, Tony Seisser
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkMSCI USA Index
CategorySize and Style
FocusLarge Cap
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$10.46 million
Average Daily Volume$2,879.60
Discount/Premium-0.01%

ETF Expenses

Management Fee0.04%
Other Expenses0.00%
Total Expenses0.04%
Fee Waiver0.00%
Net Expenses0.04%

Administrator, Advisor and Custodian

AdministratorThe Bank of New York Mellon Corporation
AdvisorInvesco Capital Management LLC
CustodianThe Bank of New York Mellon Corporation
DistributorInvesco Distributors, Inc.
Transfer AgentThe Bank of New York Mellon Corporation
Trustee
Lead Market MakerVirtu Financial

Geographic Exposure of PBUS

Currency Exposure of PBUS

Sector Exposure of PBUS

Industry Exposure of PBUS

$40.07
+0.37 (+0.93 %)
(As of 02/24/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PBUS News and Ratings via Email

Sign-up to receive the latest news and ratings for PBUS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Invesco PureBeta MSCI USA ETF (BATS:PBUS) Frequently Asked Questions

What stocks does MarketBeat like better than Invesco PureBeta MSCI USA ETF?

Wall Street analysts have given Invesco PureBeta MSCI USA ETF a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Invesco PureBeta MSCI USA ETF wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Invesco PureBeta MSCI USA ETF's stock price been impacted by Coronavirus (COVID-19)?

Invesco PureBeta MSCI USA ETF's stock was trading at $27.31 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, PBUS shares have increased by 46.7% and is now trading at $40.0699.
View which stocks have been most impacted by COVID-19.

What is Invesco PureBeta MSCI USA ETF's stock symbol?

Invesco PureBeta MSCI USA ETF trades on the BATS under the ticker symbol "PBUS."

Who are Invesco PureBeta MSCI USA ETF's major shareholders?

Invesco PureBeta MSCI USA ETF's stock is owned by many different retail and institutional investors. Top institutional shareholders include LPL Financial LLC (0.00%) and Jacobi Capital Management LLC (0.00%).

Which institutional investors are selling Invesco PureBeta MSCI USA ETF stock?

PBUS stock was sold by a variety of institutional investors in the last quarter, including Jacobi Capital Management LLC.

Which institutional investors are buying Invesco PureBeta MSCI USA ETF stock?

PBUS stock was bought by a variety of institutional investors in the last quarter, including LPL Financial LLC.

How do I buy shares of Invesco PureBeta MSCI USA ETF?

Shares of PBUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Invesco PureBeta MSCI USA ETF's stock price today?

One share of PBUS stock can currently be purchased for approximately $40.07.


This page was last updated on 2/25/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.